
Ipamorelin Peptide
Pentapeptide ghrelin-receptor ligand
- Full identity stated — CAS, sequence, formula, mass
- 7 of 7 specification figures carry a recorded primary source
- Synthesised to order — the dispatch date is confirmed with the order
- Any batch assay is published here before purchase
€32.00incl. VAT
Free EU shipping over €150.
Synthesised to order · dispatch date confirmed with your order
Supplied as a laboratory reagent for in-vitro research use only — not for human or veterinary use.
- Synthesisingto order
- In transittracked, EU-wide
- Delivereddate confirmed with the order
- No assay on file — the specification is stated on its face, not certified
- Plain packaging
- Synthesised to order — tracked, insulated EU dispatch once the batch is released
Analytical record
- Aib
- His
- D
- 2
- Nal
- D
- Phe
- Lys
- NH2
No certificate is published for this item yet. When one is, its chromatogram replaces this panel.
Specification
- Form
- Lyophilised powder, white to off-white (supplier general specification)
- Manufacturer specification 2026-09-06
- Storage
- -20 °C or dry environment; avoid repeated freeze-thaw (supplier general handling note)
- Manufacturer specification 2026-09-07
- Purity
- ≥ 98.0% (HPLC), supplier's standard specification; quotation and batch certificate pending
- Manufacturer specification 2026-09-07
7 of 7 figures above carry a recorded primary source, most recently read 2026-09-07.
Batch assays
No certificate is published for this item. It stays listed without one only because its specification is sourced. The purity in the Specification block is a stated specification for the compound, not a measurement of this batch — no measured purity figure is asserted anywhere on this page.
Research context
Ipamorelin is a synthetic pentapeptide indexed under CAS 170851-70-4 and published with the residue sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2. It was first described in the endocrinology literature in 1998; later literature, in 2012, describes it as a synthetic peptidomimetic acting on the ghrelin receptor. The reported characterisation was carried out in primary rat pituitary cell culture and in animal models, in rats and in swine. It has no marketing authorisation in the European Union and is supplied here as a laboratory chemical only.
References
Storage & handling
-20 °C or dry environment; avoid repeated freeze-thaw (supplier general handling note)
Lyophilised material is stored as stated above and reconstituted only at the point of use. Record the diluent volume with the batch: mass and volume together define the working concentration.
Concentration calculator →